AI-powered dermatology platform Cureskin raised $20 million in a Series B funding round led by HealthQuad. JSW Ventures, Khosla Ventures and Sharrp Ventures also participated in the round.
“These funds will help further enhance our AI capabilities, accelerate our growth and expand our solution offerings,” co-founder and CEO Guna Kakulapati said in a statement.
Previously raised Cureskin $5 million in Series A funding. To date, it claims to have treated around 1.5 million customers for various skin conditions through its app. He notes that more than 80% of them come from tier 2 and 3 cities.
Health tech startup focused on diabetes Sugar.fit received an additional $5 million in Series A funding from B Capital.
This brings its total Series A financingthe first round of which took place in November, at $16 million.
In a statement, the company said it would use its additional funds to expand its offerings, increase its presence and accelerate R&D in diabetes management.
Since its launch in late 2021, Sugar.fit has now served more than 30,000 users on its platform, offering a personalized, comprehensive diabetes management program that leverages continuous glucose monitoring technology and data. It has also recently started operating diabetes clinics in Bangalore, which offer a range of services such as stress therapies, live fitness and yoga sessions and VR color therapy.
Diagnostic Service Provider Cardiotracka brand of Uber Diagnostics, secured $2 million in a pre-Series A funding round led by Girish Narasimhan, an angel investor and director of an international investment banking firm.
This is in addition to $1.6 million previously raised from a cohort of high-net-worth individuals. He did not reveal where or how he would use his new funds.
Cardiotrack, which offers telemedicine kits, medical-grade and IoT diagnostic devices, and data analytics solutions, serves some of India’s largest health and life insurers along with a network of diagnostic centers in more than 300 locations.
I loved as much as you will receive carried out right here The sketch is attractive your authored material stylish nonetheless you command get got an impatience over that you wish be delivering the following unwell unquestionably come more formerly again since exactly the same nearly a lot often inside case you shield this hike